Sign in

NCT06410547Completed

Using Large Language Models Such As GPT-4 to Assess Guideline Adherence in Patients With Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov · Last updated 20 Mar 2026

Brief summary (registry, in English)

According to studies in the US and the Netherlands, 33-40% of patients with chronic conditions receive care that does not follow guideline recommendations. These findings have also been demonstrated in the management of COPD. This leads to under- or over-treatment of patients and, in the case of COPD, to exacerbations and hospitalisations. These exacerbations are a significant clinical problem, affecting patient's lung function, quality of life and mortality. They are also a burden on the healthcare system. Technological advances in artificial intelligence offer the opportunity to address these issues in COPD management. In the past year, there have been remarkable innovations in the field of natural language processing, especially through large language models such as GPT-4 from OpenAI and Bard or Gemini from Google. These models offer an opportunity to improve the implementation of evidence-based care in clinical practice. This study is a prospective, randomised trial that will compare therapy on discharge for patients with COPD. One arm will receive no intervention, while the other arm will receive a treatment recommendation from an LLM. The study will compare the percentage of patients treated according to the guideline.

Status (registry)
Completed
Study type
Interventional
Enrollment
78 (actual)
First submitted
24 Apr 2024
Start date
15 May 2024
Primary completion date
1 Apr 2025
Lead sponsor
Charite University, Berlin, Germany
Diseases
COPD
NCT number
NCT06410547

What you commit to

  • Study type: Interventional
  • Participants enrolled: 78
  • From 15 May 2024 to the primary completion date, 1 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Lack of Consent

Who the study is looking for

  • Diagnosis of COPD
  • Consent
  • Discharge after hospitalization

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Charité University
Coordinator of this site? Confirm its status
BerlinGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.